Distinct transcriptomic features are associated with transitional and mature B-cell populations in the mouse spleen

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Kleiman, Eden ^a   Salyakina, Daria ^b   De Heusch, Magali ^c,d   Hoek, Kristen L ^e   Llanes, Joan M ^e   Castro, Iris ^a   Wright, Jacqueline A ^a   Clark, Emily S ^a   Dykxhoorn, Derek M ^a   Capobianco, Enrico ^b   Takeda, Akiko ^f   Renauld, Jean Christophe ^c,d   Khan, Wasif N ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^d DE DUVE INSTITUTE   (Belgium)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DAP10 PI3K pathway; Follicular 1 and 2 B cells; IL 9 IL 9R; Marginal zone B cells; Myb Myc; Splenic transitional B cells; Toll like receptors 3 and 7; Transcriptome by RNA seq technique

Indexed keywords

CD45 ANTIGEN; INTERLEUKIN 9; MYC PROTEIN; PROTEIN MYB; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TRANSCRIPTOME;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; PRE B LYMPHOCYTE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN; WESTERN BLOTTING;

EID: 84926649961     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00030     Document Type: Article

References (98)

1. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol (2006) 6:728-40. doi: 10.1038/nri1939
2. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 190:75-89. doi:10.1084/jem.190.1.75
3. Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol (2002) 168:2101-10. doi:10.4049/jimmunol.168.5.2101
4. Meyer-Bahlburg A, Andrews SF, Yu KO, Porcelli SA, Rawlings DJ. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med (2008) 205:155-68. doi:10.1084/jem.20071088
5. Petro JB, Gerstein RM, Lowe J, Carter RS, Shinners N, Khan WN. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem (2002) 277:48009-19. doi:10.1074/jbc.M200305200
6. Hoek KL, Antony P, Lowe J, Shinners N, Sarmah B, Wente SR, et al. Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement. J Immunol (2006) 177:5405-13. doi:10.4049/jimmunol.177.8.5405
7. Castro I, Wright JA, Damdinsuren B, Hoek KL, Carlesso G, Shinners NP, et al. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol (2009) 182:7729-37. doi:10.4049/jimmunol.0803281
8. Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, Wiedeman AE, et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med (2013) 210:2773-89. doi:10.1084/jem.20122798
9. Roy V, Chang NH, Cai Y, Bonventi G, Wither J. Aberrant IgM signaling promotes survival of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand black mice. J Immunol (2005) 175:7363-71. doi:10.4049/jimmunol.175.11.7363
10. Kinnunen T, Chamberlain N, Morbach H, Cantaert T, Lynch M, Preston-Hurlburt P, et al. Specific peripheral B cell tolerance defects in patients with multiple sclerosis. J Clin Invest (2013) 123:2737-41. doi:10.1172/JCI68775
11. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol (2009) 9:767-77. doi:10.1038/nri2656
12. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr., Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol (2008) 9:54-62. doi:10.1038/ni1542
13. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol (2013) 13:118-32. doi:10.1038/nri3383
14. Cariappa A, Boboila C, Moran ST, Liu H, Shi HN, Pillai S. The recirculating B cell pool contains two functionally distinct, long-lived, posttransitional, follicular B cell populations. J Immunol (2007) 179:2270-81. doi:10.4049/jimmunol.179.4.2270
15. Takeda A, Matsuda A, Paul RM, Yaseen NR. CD45-associated protein inhibits CD45 dimerization and up-regulates its protein tyrosine phosphatase activity. Blood (2004) 103:3440-7. doi:10.1182/blood-2003-06-2083
16. Knoops L, Louahed J, Van Snick J, Renauld JC. IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol (2005) 175:335-41. doi:10.4049/jimmunol.175.1.335
17. Vink A, Warnier G, Brombacher F, Renauld JC. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med (1999) 189:1413-23. doi:10.1084/jem.189.9.1413
18. Hansen KD, Brenner SE, Dudoit S. Biases in Illumina transcriptome sequencing caused by random hexamer priming. Nucleic Acids Res (2010) 38:e131. doi:10.1093/nar/gkq224
19. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc (2012) 7:562-78. doi:10.1038/nprot.2012.016
20. Tarazona S, Garcia-Alcalde F, Dopazo J, Ferrer A, Conesa A. Differential expression in RNA-seq: a matter of depth. Genome Res (2011) 21:2213-23. doi:10.1101/gr.124321.111
21. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2009) 37:1-13. doi:10.1093/nar/gkn923
22. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 4:44-57. doi:10.1038/nprot.2008.211
23. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol (2001) 167:6834-40. doi:10.4049/jimmunol.167.12.6834
24. Won WJ, Kearney JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol (2002) 168:5605-11. doi:10.4049/jimmunol.168.11.5605
25. Benitez A, Weldon AJ, Tatosyan L, Velkuru V, Lee S, Milford TA, et al. Differences in mouse and human nonmemory B cell pools. J Immunol (2014) 192:4610-9. doi:10.4049/jimmunol.1300692
26. Laurenti E, Doulatov S, Zandi S, Plumb I, Chen J, April C, et al. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol (2013) 14:756-63. doi:10.1038/ni.2615
27. Moroy T, Khandanpour C. Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation. Semin Immunol (2011) 23:368-78. doi:10.1016/j.smim.2011.08.006
28. Suzuki N, Yoshioka N, Uekawa A, Matsumura N, Tozawa A, Koike J, et al. Transcription factor POU6F1 is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target. Int J Gynecol Cancer (2010) 20:212-9. doi:10.1111/IGC.0b013e3181c97ae0
29. Hoek KL, Gordy LE, Collins PL, Parekh VV, Aune TM, Joyce S, et al. Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Immunity (2010) 33:254-65. doi:10.1016/j.immuni.2010.07.016
30. Wang HS, Feng JX, Qi CF, Li ZY, Morse HC, Clarke SH. Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection. J Immunol (2007) 179:7544-52. doi:10.4049/jimmunol.179.11.7544
31. Bretones G, Delgado MD, Leon J. Myc and cell cycle control. Biochim Biophys Acta (2014). doi:10.1016/j.bbagrm.2014.03.013
32. Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N, et al. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res (2012) 72:2622-33. doi:10.1158/0008-5472.CAN-11-3605
33. Zhu J, Blenis J, Yuan J. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci U S A (2008) 105:6584-9. doi:10.1073/pnas.0802785105
34. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol (2003) 4:287-94. doi:10.1038/ni892
35. Arnold HK, Sears RC. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol (2006) 26:2832-44. doi:10.1128/MCB.26.7.2832-2844.2006
36. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 1:a000034. doi:10.1101/cshperspect.a000034
37. Tsygankova OM, Prendergast GV, Puttaswamy K, Wang Y, Feldman MD, Wang H, et al. Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol (2007) 27:6647-58. doi:10.1128/MCB.00155-07
38. Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol (2012) 13:195-203. doi:10.1038/nrm3290
39. Qiao G, Li Z, Molinero L, Alegre ML, Ying H, Sun Z, et al. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol (2008) 28:2470-80. doi:10.1128/MCB.01505-07
40. von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity (2001) 14:573-82. doi:10.1016/S1074-7613(01)00130-3
41. Dai X, James RG, Habib T, Singh S, Jackson S, Khim S, et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest (2013) 123:2024-36. doi:10.1172/JCI66963
42. Fousteri G, Liossis SN, Battaglia M. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol (2013) 149:556-65. doi:10.1016/j.clim.2013.10.006
43. Heng TS, Painter MW, Immunological Genome Project C. The immunological genome project: networks of gene expression in immune cells. Nat Immunol (2008) 9:1091-4. doi:10.1038/ni1008-1091
44. Knoops L, Louahed J, Renauld JC. IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice. J Immunol (2004) 172:6101-6. doi:10.4049/jimmunol.172.10.6101
45. Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 23:1687-92. doi:10.1002/eji.1830230743
46. Petit-Frere C, Dugas B, Braquet P, Mencia-Huerta JM. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology (1993) 79:146-51.
47. Faulkner H, Humphreys N, Renauld JC, Van Snick J, Grencis R. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol (1997) 27:2536-40. doi:10.1002/eji.1830271011
48. Steenwinckel V, Louahed J, Orabona C, Huaux F, Warnier G, McKenzie A, et al. IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol (2007) 178:3244-51. doi:10.4049/jimmunol.178.5.3244
49. Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol (2007) 178:7531-9. doi:10.4049/jimmunol.178.12.7531
50. Ranjan P, Bowzard JB, Schwerzmann JW, Jeisy-Scott V, Fujita T, Sambhara S. Cytoplasmic nucleic acid sensors in antiviral immunity. Trends Mol Med (2009) 15:359-68. doi:10.1016/j.molmed.2009.06.003
51. Mehrpour M, Esclatine A, Beau I, Codogno P. Overview of macroautophagy regulation in mammalian cells. Cell Res (2010) 20:748-62. doi:10.1038/cr.2010.82
52. McCormack R, de Armas LR, Shiratsuchi M, Ramos JE, Podack ER. Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1. J Innate Immun (2013) 5:185-94. doi:10.1159/000345249
53. Perwitasari O, Cho H, Diamond MS, Gale M Jr. Inhibitor of kappaB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J Biol Chem (2011) 286:44412-23. doi:10.1074/jbc.M111.285205
54. Spierings DC, McGoldrick D, Hamilton-Easton AM, Neale G, Murchison EP, Hannon GJ, et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood (2011) 117:5340-9. doi:10.1182/blood-2010-10-316034
55. Turchinovich G, Vu TT, Frommer F, Kranich J, Schmid S, Alles M, et al. Programming of marginal zone B-cell fate by basic Kruppel-like factor (BKLF/KLF3). Blood (2011) 117:3780-92. doi:10.1182/blood-2010-09-308742
56. Mabbott NA, Gray D. Identification of co-expressed gene signatures in mouse B1, marginal zone and B2 B-cell populations. Immunology (2014) 141:79-95. doi:10.1111/imm.12171
57. Kin NW, Crawford DM, Liu J, Behrens TW, Kearney JF. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J Immunol (2008) 180:6663-74. doi:10.4049/jimmunol.180.10.6663
58. Debnath I, Roundy KM, Dunn DM, Weiss RB, Weis JJ, Weis JH. Defining a transcriptional fingerprint of murine splenic B-cell development. Genes Immun (2008) 9:706-20. doi:10.1038/gene.2008.70
59. Debnath I, Roundy KM, Weis JJ, Weis JH. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes. J Immunol (2007) 178:7139-50. doi:10.4049/jimmunol.178.11.7139
60. Carey JB, Moffatt-Blue CS, Watson LC, Gavin AL, Feeney AJ. Repertoire-based selection into the marginal zone compartment during B cell development. J Exp Med (2008) 205:2043-52. doi:10.1084/jem.20080559
61. Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K, et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity (2001) 14:603-15. doi:10.1016/S1074-7613(01)00135-2
62. Guerrier T, Youinou P, Pers JO, Jamin C. TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity. J Autoimmun (2012) 39:173-9. doi:10.1016/j.jaut.2012.05.012
63. Labi V, Erlacher M, Kiessling S, Manzl C, Frenzel A, O'Reilly L, et al. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med (2008) 205:641-55. doi:10.1084/jem.20071658
64. Karnell FG, Brezski RJ, King LB, Silverman MA, Monroe JG. Membrane cholesterol content accounts for developmental differences in surface B cell receptor compartmentalization and signaling. J Biol Chem (2005) 280:25621-8. doi:10.1074/jbc.M503162200
65. Gelman IH. Emerging roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis. Genes Cancer (2010) 1:1147-56. doi:10.1177/1947601910392984
66. Smarda J, Sugarman J, Glass C, Lipsick J. Retinoic acid receptor alpha suppresses transformation by v-myb. Mol Cell Biol (1995) 15:2474-81.
67. Knoepfler PS. Myc goes global: new tricks for an old oncogene. Cancer Res (2007) 67:5061-3. doi:10.1158/0008-5472.CAN-07-0426
68. Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity (2011) 35:871-82. doi:10.1016/j.immuni.2011.09.021
69. Iritani BM, Eisenman RN. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A (1999) 96:13180-5. doi:10.1073/pnas.96.23.13180
70. Poutanen M, Huhtaniemi I, Bjorkgren I. Loss of Bmyc results in increased apoptosis associated with upregulation of Myc expression in juvenile murine testis. Reproduction (2012) 144:495-503. doi:10.1530/REP-11-0444
71. Lanier LL. DAP10-and DAP12-associated receptors in innate immunity. Immunol Rev (2009) 227:150-60. doi:10.1111/j.1600-065X.2008.00720.x
72. Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, et al. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum (2008) 58:3192-204. doi:10.1002/art.23812
73. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, et al. Double-hit B-cell lymphomas. Blood (2011) 117:2319-31. doi:10.1182/blood-2010-09-297879
74. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (1992) 359:552-4. doi:10.1038/359552a0
75. Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov (2010) 9:482-93. doi:10.1038/nrd3030
76. Hamel KM, Cao Y, Olalekan SA, Finnegan A. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice. Arthritis Rheumatol (2014) 66:60-7. doi:10.1002/art.38207
77. Ettinger R, Mebius R, Browning JL, Michie SA, van Tuijl S, Kraal G, et al. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. Int Immunol (1998) 10:727-41. doi:10.1093/intimm/10.6.727
78. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, et al. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 27:2600-9. doi:10.1002/eji.1830271020
79. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity (2008) 28:183-96. doi:10.1016/j.immuni.2007.11.024
80. Hermiston ML, Tan AL, Gupta VA, Majeti R, Weiss A. The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity (2005) 23:635-47. doi:10.1016/j.immuni.2005.11.001
81. Leitenberg D, Falahati R, Lu DD, Takeda A. CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck. Immunology (2007) 121:545-54. doi:10.1111/j.1365-2567.2007.02602.x
82. Ding I, Bruyns E, Li P, Magada D, Paskind M, Rodman L, et al. Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. Eur J Immunol (1999) 29:3956-61. doi:10.1002/(SICI)1521-4141(199912)29:12<3956::AID-IMMU3956>3.0.CO;2-G
83. Matsuda A, Motoya S, Kimura S, McInnis R, Maizel AL, Takeda A. Disruption of lymphocyte function and signaling in CD45-associated protein-null mice. J Exp Med (1998) 187:1863-70. doi:10.1084/jem.187.11.1863
84. Cahir McFarland ED, Pingel J, Thomas ML. Definition of amino acids sufficient for plasma membrane association of CD45 and CD45-associated protein. Biochemistry (1997) 36:7169-75. doi:10.1021/bi970013y
85. Kitamura K, Matsuda A, Motoya S, Takeda A. CD45-associated protein is a lymphocyte-specific membrane protein expressed in two distinct forms. Eur J Immunol (1997) 27:383-8. doi:10.1002/eji.1830270207
86. Motoya S, Kitamura K, Matsuda A, Maizel AL, Yamamoto H, Takeda A. Interaction between CD45-AP and protein-tyrosine kinases involved in T cell receptor signaling. J Biol Chem (1999) 274:1407-14. doi:10.1074/jbc.274.3.1407
87. Cahir McFarland ED, Thomas ML. CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region. J Biol Chem (1995) 270:28103-7. doi:10.1074/jbc.270.47.28103
88. Veillette A, Soussou D, Latour S, Davidson D, Gervais FG. Interactions of CD45-associated protein with the antigen receptor signaling machinery in T-lymphocytes. J Biol Chem (1999) 274:14392-9. doi:10.1074/jbc.274.20.14392
89. Kung C, Okumura M, Seavitt JR, Noll ME, White LS, Pingel JT, et al. CD45-associated protein is not essential for the regulation of antigen receptor-mediated signal transduction. Eur J Immunol (1999) 29:3951-5. doi:10.1002/(SICI)1521-4141(199912)29:12<3951::AID-IMMU3951>3.0.CO;2-9
90. Welte T, Zhang SS, Wang T, Zhang Z, Hesslein DG, Yin Z, et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A (2003) 100:1879-84. doi:10.1073/pnas.0237137100
91. Grohmann U, Van Snick J, Campanile F, Silla S, Giampietri A, Vacca C, et al. IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J Immunol (2000) 164:4197-203. doi:10.4049/jimmunol.164.8.4197
92. Claas C, Stipp CS, Hemler ME. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem (2001) 276:7974-84. doi:10.1074/jbc.M008650200
93. Le Naour F, Andre M, Boucheix C, Rubinstein E. Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics (2006) 6:6447-54. doi:10.1002/pmic.200600282
94. Leung KT, Chan KY, Ng PC, Lau TK, Chiu WM, Tsang KS, et al. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells. Blood (2011) 117:1840-50. doi:10.1182/blood-2010-04-281329
95. Cariappa A, Shoham T, Liu H, Levy S, Boucheix C, Pillai S. The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity. J Immunol (2005) 175:2925-30. doi:10.4049/jimmunol.175.5.2925
96. Maeurer C, Holland S, Pierre S, Potstada W, Scholich K. Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. Cell Signal (2009) 21:293-300. doi:10.1016/j.cellsig.2008.10.016
97. Han S, Witt RM, Santos TM, Polizzano C, Sabatini BL, Ramesh V. Pam (Protein associated with Myc) functions as an E3 Ubiquitin ligase and regulates TSC/mTOR signaling. Cell Signal (2008) 20:1084-91. doi:10.1016/j.cellsig.2008.01.020
98. Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol (2012) 30:39-68. doi:10.1146/annurev-immunol-020711-075024